Canadian Perspectives
The CCS Canadian Perspectives Program is a unique program that allows the cardiovascular community to hear about the latest research findings from international experts presented at the American College of Cardiology (ACC) Scientific Sessions, the European Society of Cardiology Congress (ESC) and the American Heart Association (AHA) Meeting. These perspectives can impact profound changes and improvements in their clinical approach.
Planning Committee:
Dr. Anil Gupta, Chair (Ontario)
Dr. Grace Chua (Ontario)
Dr. David Bewick (New Brunswick)
Dr. Benny Lau (British Columbia)
Dr. Vineeta Ahooja (Ontario)
Dr. Chi-Ming Chow, Continuing Professional Development Committee, Chair (Ontario)
American College of Cardiology 2023 (ACC 2023)
To watch any of the recorded webinars, please click below.
May 3, 2023
Canadian Perspectives on the ACC 2023 – Session 1
- LIVE-HCM
- RETURN-TO-PLAY
- ENDURANCE
- STELLAR PHASE III
June 02, 2023
Canadian Perspectives on the ACC 2023 – Session 3
- Oral PCSK9 Inhibitor Trial
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity and balance.
American Heart Association Scientific Sessions 2022 (AHA 2022)
To watch the recorded webinar, please click below.
December 7, 2022
Canadian Perspectives on the AHA 2022
PROGRESSIVE-AF
RAPID
DOSE VF
This program was made possible through an educational grant from our industry partner and was planned to achieve scientific integrity, objectivity and balance.
European Society of Cardiology (ESC) Congress 2022
To watch any of the recorded webinars, please click below.
Click any of the trials below to view specific presentations.
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity, and balance.
American College of Cardiology 2022 (ACC 2022)
To watch any of the recorded webinars, please click below.
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity and balance.
American Heart Association Scientific Sessions 2021 (AHA 2021)
To watch any of the recorded webinars, please click below.
Click any of the trials below to view specific presentations.
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity and balance
European Society of Cardiology (ESC) Congress 2021
To watch any of the recorded webinars, please click the topics below.
Click any of the trials below to view specific presentations.
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity and balance.
American College of Cardiology 2021 (ACC 2021)
To watch the recorded webinar, please click the link below.
June 15, 2021
Canadian Perspectives on the ACC 2.0
- Paradise-MI
- Atlantis
June 2, 2021
Canadian Perspectives on the ACC 2021 – Session 1
- Left Atrial Appendage Occlusion Study (LAAOS) III
- Explorer-HCM
- HOST-EXAM
This program was made possible by an educational grant from BMS/Pfizer Alliance and was planned to achieve scientific integrity, objectivity and balance.
American Heart Association Scientific Sessions 2020 (AHA 2020)
To watch the recorded webinar, please click the link below.
December 16, 2020
AHA 2020
- GALACTIC HF
- SEARCH AF
- EARLY AF
- RIVER
This program was made possible in part by an educational grant from Bayer and was planned to achieve scientific integrity, objectivity and balance.
European Society of Cardiology (ESC) Congress
To watch any of the recorded webinars, please click the topics below.
September 16, 2020
Atrial Fibrillation & CAD
- EAST – AFNET 4: Effects of Early Rhythm Control Therapy in Patients with Atrial Fibrillation
- EVAPORATE – Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy
- LoDoCo2 Low-Dose Colchicine in Coronary Disease
September 23, 2020
Heart Failure
- EMPEROR-Reduced: Empagliflozin in Heart Failure With a Reduced Ejection Fraction, With and Without Diabetes
- EXPLORER-HCM: Efficacy and Safety of Mavacamten in Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
- PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF
Click any of the trials below to view specific presentations.
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity and balance
American College of Cardiology (ACC) Scientific Sessions
To watch any of the recorded webinars, please click the topic below.
Click any of the trials below to view specific whiteboard presentations.
This program was made possible through educational grants from our industry partners and was planned to achieve scientific integrity, objectivity and balance.
